Reducing Urban Cervical Cancer Disparities
NCT06416150 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 546
Last updated 2024-10-26
Summary
This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.
Conditions
- Cervical Cancer
- Papilloma Viral Infection
Interventions
- BEHAVIORAL
-
Stage 1 SOC
Participants will receive high Standard Care, consisting of a telephone call approximately one month before the appointment to confirm the appointment date for the baseline colposcopy appointment, followed by a notification letter including scheduled appointment date and clinic contact information should the clinic be unable to reach the patient by telephone.
- BEHAVIORAL
-
Stage 1 HERS
Participants will receive text message appointment reminders and barriers messages. Text messages will be sent on a prescheduled basis over the course of 2 weeks preceding the scheduled target appointment.
- BEHAVIORAL
-
Stage 2 HERS
Participants will receive another barriers assessment and another round of text message appointment reminders and barriers messages.
- BEHAVIORAL
-
Stage 2 HERS+HC
Participants will receive another barriers assessment and another round of text message barriers counseling as well as health coaching (HC) after their missed appointment. Participants that miss their scheduled appointment will receive a HC call within 2 business days. HC calls will be flexibly scheduled based on the preference of the patients and limited to 15 minutes or less.
- BEHAVIORAL
-
Stage 3 SOC
Participants will receive a telephone call before their 12-month follow-up appointments to remind participants about their upcoming appointment and schedule/reschedule if needed.
- BEHAVIORAL
-
Stage 3 HERS
Participants will receive text message appointment reminders and barriers messages. Text messages will be sent on a prescheduled basis over the course of 2 weeks preceding the scheduled target appointment.
- BEHAVIORAL
-
Stage 3 HERS+HC
Participants will receive text message barriers counseling as well as HC after their missed appointment. Participants that miss their scheduled appointment will receive a HC call within 2 business days. HC calls will be flexibly scheduled based on the preference of the patients and limited to 15 minutes or less.
- BEHAVIORAL
-
Stage 4 HERS
Participants will receive another barriers assessment and another round of text message appointment reminders and barriers messages.
- BEHAVIORAL
-
Stage 4 HERS+HC
Participants will receive another barriers assessment and another round of text message barriers counseling as well as HC. Participants that miss their scheduled appointment will receive a HC call within 2 business days. HC calls will be flexibly scheduled based on the preference of the patients and limited to 15 minutes or less.
Sponsors & Collaborators
-
Rutgers, The State University of New Jersey
collaborator OTHER -
Thomas Jefferson University
collaborator OTHER -
Temple University
collaborator OTHER -
University of South Carolina
collaborator OTHER -
Fox Chase Cancer Center
lead OTHER
Principal Investigators
-
Suzanne M Miller, PhD · Fox Chase Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-08-28
- Primary Completion
- 2027-04-30
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida
NCT02202109 ·Status: COMPLETED ·Phase: NA
-
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
NCT04679675 ·Status: COMPLETED ·Phase: NA
-
Clinic-based Intervention to Promote Cervical Cancer Prevention Behaviors
NCT02046265 ·Status: COMPLETED ·Phase: NA
-
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01588301 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
My Self-Sampling for HPV Awareness, Results, and Empowerment
NCT07296159 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Conducting Outreach to Improve Cervical Cancer Screening Rates Among Underscreened Patients
NCT02427399 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence
NCT00682552 ·Status: TERMINATED ·Phase: NA
-
Effectiveness of an EHealth Intervention for Uptake of Cervical Cancer Screening in Hispanic Women
NCT06741241 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cervical Cancer Self-Collection for Southeast Asian Immigrant and Refugee Women
NCT05286749 ·Status: COMPLETED ·Phase: NA
-
Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rate
NCT05458960 ·Status: TERMINATED ·Phase: NA
-
Cervical Cancer Screening Intervention Among Korean American Women
NCT02594826 ·Status: COMPLETED ·Phase: NA
-
Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
NCT07209917 ·Status: RECRUITING ·Phase: NA
-
A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening
NCT01058148 ·Status: COMPLETED
-
HPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks
NCT06414057 ·Status: RECRUITING
-
Evaluation of an Mhealth Intervention to Increase Adherence to Triage of HPV+ Women
NCT02561208 ·Status: WITHDRAWN ·Phase: NA
-
Self-Collection and Human Papillomavirus (HPV) Testing in Unscreened Women: a Feasibility Study in Brazil
NCT03713697 ·Status: COMPLETED ·Phase: NA
-
Human Papilloma Virus (HPV) Self-collection and Women Adherence
NCT05059015 ·Status: UNKNOWN ·Phase: NA
-
Development & Validation of Utilities for Health States Relevant to Cervical Cancer Patients
NCT00788216 ·Status: COMPLETED
-
Human Papilloma Virus (HPV) Vaccination Among Rural African American Primary Caregivers and Daughters
NCT00937287 ·Status: COMPLETED
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)
NCT06611553 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Dissemination of Cervical Cancer Screening to Primary Care Physicians in Underserved Communities
NCT00629993 ·Status: TERMINATED ·Phase: PHASE4
-
Optimization of Cervical Cancer Screening Strategies Among Women Living With HIV: Effectiveness and Implementation of Decentralized Approach Using a Mobile Team With HPV Testing in the Western Region of Cameroon
NCT07181278 ·Status: RECRUITING ·Phase: NA
-
Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa
NCT05414097 ·Status: COMPLETED
-
Remote Resilience: Novel Applications of mHealth in Nicaragua's Cancer Control Program
NCT06921798 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers
NCT01051895 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA